| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.50▲ | 1.51▲ | 1.51▲ | 1.62▼ | 1.54▼ |
| MA10 | 1.50▲ | 1.51▲ | 1.52▼ | 1.60▼ | 1.54▼ |
| MA20 | 1.51▲ | 1.53▼ | 1.56▼ | 1.54▼ | 1.79▼ |
| MA50 | 1.51▲ | 1.63▼ | 1.68▼ | 1.49▲ | 2.90▼ |
| MA100 | 1.53▼ | 1.67▼ | 1.56▼ | 1.93▼ | 6.02▼ |
| MA200 | 1.58▼ | 1.56▼ | 1.55▼ | 2.71▼ | 7.39▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.006▲ | -0.002▼ | 0.005▲ | 0.102▲ |
| RSI | 53.919▲ | 41.294▼ | 39.402▼ | 48.017▼ | 39.459▼ |
| STOCH | 46.667 | 36.795 | 18.403▼ | 37.309 | 50.477 |
| WILL %R | 0.000▲ | -61.538 | -76.190▼ | -75.287▼ | -57.986 |
| CCI | 137.172▲ | -22.999 | -79.187 | -20.411 | -3.762 |
|
Wednesday, June 11, 2025 03:32 PM
MacroGenics' recent royalty deal extends cash runway, but liquidity concerns remain, and further asset sales or dilution may be necessary. Read why MGNX is a Buy.
|
|
Tuesday, June 10, 2025 08:05 AM
MacroGenics (MGNX) stock gains as the company secures $70M upfront from Sagard via royalty rights deal for its cancer therapy retifanlimab. Read more here.
|
|
Wednesday, May 28, 2025 07:48 AM
Macrogenics Inc. (NASDAQ:MGNX) stock has reached a 52-week low, touching down at $2.95, as the biopharmaceutical company faces a challenging market environment. According to InvestingPro analysis ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/06/25 | 1.49 | 1.54 | 1.49 | 1.515 | 461,713 |
| 13/06/25 | 1.50 | 1.595 | 1.48 | 1.52 | 955,190 |
| 12/06/25 | 1.66 | 1.68 | 1.55 | 1.55 | 1,616,525 |
| 11/06/25 | 1.82 | 2.01 | 1.70 | 1.71 | 3,355,622 |
| 10/06/25 | 2.02 | 2.17 | 1.78 | 1.79 | 25,552,726 |
| 09/06/25 | 1.80 | 1.81 | 1.63 | 1.64 | 389,446 |
| 06/06/25 | 1.49 | 1.855 | 1.4896 | 1.78 | 1,910,376 |
| 05/06/25 | 1.50 | 1.50 | 1.42 | 1.45 | 257,661 |
| 04/06/25 | 1.51 | 1.535 | 1.49 | 1.50 | 396,155 |
| 03/06/25 | 1.40 | 1.5286 | 1.35 | 1.51 | 360,967 |
|
|
||||
|
|
||||
|
|